Aurobindo Pharma’s unit recalling 88,080 vials of Tranexamic acid injection

25 Oct 2022 Evaluate

Aurobindo Pharma’s unit -- AuroMedics Pharma LLC is recalling 88,080 vials of Tranexamic acid injection, which is used to control or prevent excessive or heavy bleeding during various conditions like dental procedures in patients.

The East Windsor-based drug firm is recalling the affected lot due to the ‘presence of particulate matter: piece of metal found in a vial’. AuroMedics commenced the Class III recall in the US on September 26.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1149.10 8.80 (0.77%)
21-Jan-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.15
Dr. Reddys Lab 1178.00
Cipla 1383.00
Zydus Lifesciences 877.25
Lupin 2188.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×